Phantom3349
2021-05-04
Buy Nio and Tesla. Perfect combination.
Is Now The Time To Buy Stock In Ocugen, Tilray Or Nio?
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
7
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":106991014,"tweetId":"106991014","gmtCreate":1620082670638,"gmtModify":1631889780368,"author":{"id":3560474608445356,"idStr":"3560474608445356","authorId":3560474608445356,"authorIdStr":"3560474608445356","name":"Phantom3349","avatar":"https://static.tigerbbs.com/b4f01e313c95d322d9a45d857cec332a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":91,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Buy Nio and Tesla. Perfect combination.</p></body></html>","htmlText":"<html><head></head><body><p>Buy Nio and Tesla. Perfect combination.</p></body></html>","text":"Buy Nio and Tesla. Perfect combination.","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/106991014","repostId":1188362476,"repostType":4,"repost":{"id":"1188362476","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1620049664,"share":"https://www.laohu8.com/m/news/1188362476?lang=&edition=full","pubTime":"2021-05-03 21:47","market":"us","language":"en","title":"Is Now The Time To Buy Stock In Ocugen, Tilray Or Nio?","url":"https://stock-news.laohu8.com/highlight/detail?id=1188362476","media":"Benzinga","summary":"One of the most common questions traders have about stocks is “Why Is It Moving?”\nThat’s why Benzing","content":"<p>One of the most common questions traders have about stocks is “Why Is It Moving?”</p>\n<p>That’s why Benzinga created the Why Is It Moving, or WIIM, feature inBenzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.</p>\n<p>Here’s the latest news and updates for Ocugen, Tilray and Nio.</p>\n<p><b>Ocugen Inc</b>(NASDAQ:OCGN) shares are trading higher by 13.2% at $14.35 after the company announced studies showing COVAXIN is potentially effective against three key variants of SARS-CoV-2…<i>Read More</i></p>\n<p>Ocugen is a clinical-stage biopharmaceutical company. More than the COVID-19 vaccine, the company is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.</p>\n<p><b>Tilray Inc</b>(NASDAQ:TLRY) shares are trading higher by 2% at $18.74 after the company completed its merger with Aphria.</p>\n<p>The combined company, which will operate as Tilray, brings together two highly complementary businesses to create the leading cannabis-focused consumer packaged goods company with the largest global geographic footprint in the industry.</p>\n<p>The combined company had a market cap of approximately $8.2 billion based on the closing stock prices on April 30.</p>\n<p><b>Nio Inc – ADR</b>(NYSE:NIO) has signed a strategic cooperation agreement with the University of Science and Technology of China (USTC) to cooperate in smart EV technology research, cnEVpost reported Sunday.</p>\n<p>The two will establish the USTC-NIO Smart Electric Vehicle Joint Laboratory to conduct joint research on major national as well as local projects…</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Now The Time To Buy Stock In Ocugen, Tilray Or Nio?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Now The Time To Buy Stock In Ocugen, Tilray Or Nio?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-05-03 21:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>One of the most common questions traders have about stocks is “Why Is It Moving?”</p>\n<p>That’s why Benzinga created the Why Is It Moving, or WIIM, feature inBenzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.</p>\n<p>Here’s the latest news and updates for Ocugen, Tilray and Nio.</p>\n<p><b>Ocugen Inc</b>(NASDAQ:OCGN) shares are trading higher by 13.2% at $14.35 after the company announced studies showing COVAXIN is potentially effective against three key variants of SARS-CoV-2…<i>Read More</i></p>\n<p>Ocugen is a clinical-stage biopharmaceutical company. More than the COVID-19 vaccine, the company is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.</p>\n<p><b>Tilray Inc</b>(NASDAQ:TLRY) shares are trading higher by 2% at $18.74 after the company completed its merger with Aphria.</p>\n<p>The combined company, which will operate as Tilray, brings together two highly complementary businesses to create the leading cannabis-focused consumer packaged goods company with the largest global geographic footprint in the industry.</p>\n<p>The combined company had a market cap of approximately $8.2 billion based on the closing stock prices on April 30.</p>\n<p><b>Nio Inc – ADR</b>(NYSE:NIO) has signed a strategic cooperation agreement with the University of Science and Technology of China (USTC) to cooperate in smart EV technology research, cnEVpost reported Sunday.</p>\n<p>The two will establish the USTC-NIO Smart Electric Vehicle Joint Laboratory to conduct joint research on major national as well as local projects…</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc.","OCGN":"Ocugen","NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188362476","content_text":"One of the most common questions traders have about stocks is “Why Is It Moving?”\nThat’s why Benzinga created the Why Is It Moving, or WIIM, feature inBenzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.\nHere’s the latest news and updates for Ocugen, Tilray and Nio.\nOcugen Inc(NASDAQ:OCGN) shares are trading higher by 13.2% at $14.35 after the company announced studies showing COVAXIN is potentially effective against three key variants of SARS-CoV-2…Read More\nOcugen is a clinical-stage biopharmaceutical company. More than the COVID-19 vaccine, the company is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.\nTilray Inc(NASDAQ:TLRY) shares are trading higher by 2% at $18.74 after the company completed its merger with Aphria.\nThe combined company, which will operate as Tilray, brings together two highly complementary businesses to create the leading cannabis-focused consumer packaged goods company with the largest global geographic footprint in the industry.\nThe combined company had a market cap of approximately $8.2 billion based on the closing stock prices on April 30.\nNio Inc – ADR(NYSE:NIO) has signed a strategic cooperation agreement with the University of Science and Technology of China (USTC) to cooperate in smart EV technology research, cnEVpost reported Sunday.\nThe two will establish the USTC-NIO Smart Electric Vehicle Joint Laboratory to conduct joint research on major national as well as local projects…","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["03326"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/106991014"}
精彩评论